Switch theme
Sign up to access all valuation multiples
Zortrax SA is a Polish developer of comprehensive 3D printing solutions. It is engaged in desktop 3D printers, dedicated filaments, Z-SUITE software, and additional devices to improve the printing process and post-processing.
2011
n/a
LTM Revenue n/a
LTM EBITDA n/a
$1.5M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Zortrax has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Zortrax achieved revenue of $1.7M and an EBITDA of -$1.6M.
Zortrax expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Zortrax valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $4.0M | $1.7M | XXX | XXX | XXX |
| Gross Profit | $4.6M | $1.9M | XXX | XXX | XXX |
| Gross Margin | 114% | 112% | XXX | XXX | XXX |
| EBITDA | -$22.1M | -$1.6M | XXX | XXX | XXX |
| EBITDA Margin | -551% | -92% | XXX | XXX | XXX |
| Net Profit | -$2.3M | -$23.1M | XXX | XXX | XXX |
| Net Margin | -58% | -1360% | XXX | XXX | XXX |
| Net Debt | $1.3M | $1.4M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 13, 2025, Zortrax's stock price is PLN 0 (or $0).
Zortrax has current market cap of PLN 8.0M (or $2.1M), and EV of PLN 5.8M (or $1.5M).
See Zortrax trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.5M | $2.1M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 13, 2025, Zortrax has market cap of $2.1M and EV of $1.5M.
Zortrax's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Zortrax's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Zortrax and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $1.5M | XXX | XXX | XXX |
| EV/Revenue | 0.9x | XXX | XXX | XXX |
| EV/EBITDA | -1.0x | XXX | XXX | XXX |
| P/E | -0.9x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -4.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialZortrax's NTM/LTM revenue growth is n/a
Zortrax's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Zortrax's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Zortrax's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Zortrax and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -57% | XXX | XXX | XXX | XXX |
| EBITDA Margin | N/A | XXX | XXX | XXX | XXX |
| EBITDA Growth | -93% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | N/A | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 2% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| BigRep | XXX | XXX | XXX | XXX | XXX | XXX |
| Infinitt Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Renishaw | XXX | XXX | XXX | XXX | XXX | XXX |
| Xaar | XXX | XXX | XXX | XXX | XXX | XXX |
| Solid World Grp | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Zortrax acquired XXX companies to date.
Last acquisition by Zortrax was XXXXXXXX, XXXXX XXXXX XXXXXX . Zortrax acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Zortrax founded? | Zortrax was founded in 2011. |
| Where is Zortrax headquartered? | Zortrax is headquartered in Poland. |
| Is Zortrax publicy listed? | Yes, Zortrax is a public company listed on WAR. |
| What is the stock symbol of Zortrax? | Zortrax trades under ZRX ticker. |
| When did Zortrax go public? | Zortrax went public in 2015. |
| Who are competitors of Zortrax? | Similar companies to Zortrax include e.g. BigRep, Infinitt Healthcare, Renishaw, Xaar. |
| What is the current market cap of Zortrax? | Zortrax's current market cap is $2.1M |
| What is the current revenue growth of Zortrax? | Zortrax revenue growth between 2023 and 2024 was -57%. |
| Is Zortrax profitable? | Yes, Zortrax is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
